跳至主要内容
临床试验/jRCT2080222564
jRCT2080222564未知3 期

Long-Term Study of CN-801 - Open-label study in patients with excessive daytime sleepiness associated with idiopathic hypersomnia -

Alfresa Pharma Corporation0 个研究点开始时间: 待定

试验速览

阶段
3 期
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
干预模型
Uncontrolled, open-label, multi-center study

入排标准

年龄范围
16age old over 至 64age old under(—)
性别
All

入选标准

  • Patients diagnosed with idiopathic hypersomnia based on the International Classification of Sleep Disorders, second edition (ICSD-2) and who have completed the preceding double-blind comparative study

排除标准

  • Patients with narcolepsy, restless legs syndrome, periodic limb movement disorder, or sleep apnea syndrome
  • Patients working irregular shifts or night shifts
  • Patients with chronic sleep deprivation or patients with extremely irregular bed times

结局指标

主要结局

-

Safty, Efficacy (Japanese version of the Epworth Sleepiness Scale)

次要结局

未报告次要终点

研究者

相似试验